Abstract
Multiphoton microscopy has attracted increasing attention and investigations in the field of breast cancer, based on two-photon excited fluorescence (TPEF) and second-harmonic generation (SHG). However, the incidence of breast benign diseases is about 5 to 10 times higher than breast cancer; up to 30% of women suffer from breast benign diseases and require treatment at some time in their lives. Thus, in this study, MPM was applied to image fibroadenoma and fibrocystic lesion, which are two of the most common breast benign diseases. The results show that MPM has the capability to identify the microstructure of lobule and stroma in normal breast tissue, the interaction of compressed ducts with surrounding collagen fiber in fibroadenoma, and the architecture of cysts filled with cystic fluid in fibrocystic disease. These findings indicate that, with integration of MPM into currently accepted clinical imaging system, it has the potential to make a real-time diagnosis of breast benign diseases in vivo, as well as breast cancer.
References
Aug 10, 2000·Neoplasia : an International Journal for Oncology Research·N Ramanujam
May 11, 2001·American Journal of Clinical Pathology·A KuijperP J van Diest
Jun 21, 2003·Optics Letters·Juergen C Jung, Mark J Schnitzer
Oct 12, 2005·Biotechnology Annual Review·Monica Monici
Nov 21, 2007·Optics Letters·D G OuzounovAlexander L Gaeta
Jul 8, 2008·Journal of Biomedical Optics·Paolo P ProvenzanoKevin W Eliceiri
Mar 28, 2009·Current Opinion in Biotechnology·Volker AndresenPeter Friedl
Aug 21, 2006·Optics Express·Shuangmu ZhuoDingsong Zou
Apr 5, 2011·Gastrointestinal Endoscopy·Jianxin ChenShusen Xie
Oct 28, 2011·Journal of Biomedical Optics·Demirhan KobatChris Xu
May 9, 2012·Journal of Biomedical Optics·Christopher M BrownChris Xu
May 9, 2012·Biomedical Optics Express·David M HulandChris Xu
Nov 23, 2012·Journal of Biomedical Optics·Kathleen BurkeEdward Brown
Jun 12, 2013·PloS One·Xiufeng WuJun Yan
Dec 7, 2013·Nature Photonics·Erich E Hoover, Jeff A Squier